Rowland Charles A Jr (CIK 1383292) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-09). Recent activity: Sell GBIO (53,475 shares), Buy VKTX (3,150 shares), Buy VKTX (16,000 shares), Buy VKTX (22,000 shares), Buy VKTX (22,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-09 | Generation Bio Co. (GBIO) | Director | Sell | 53,475 | $0 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 3,150 | $0 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 16,000 | $71,680 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 22,000 | $127,600 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 22,000 | $107,360 |
| 2025-10-28 | Viking Therapeutics, Inc. (VKTX) | Director | Sell | 60,000 | $2.1M |
Source: SEC Form 4 filings · as of 2026-02-09